Adagen

Active Ingredient(s): Pegademase Bovine
FDA Approved: * March 21, 1990
Pharm Company: * ENZON
Category: Immune System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Adagen Overview

PEGylation (often styled pegylation) is the process of both covalent and non-covalent attachment or amalgamation of polyethylene glycol (PEG, in pharmacy called macrogol) polymer chains to molecules and macrostructures, such as a drug, therapeutic protein or vesicle, which is then described as PEGylated (pegylated).[1][2][3] PEGylation is routinely achieved by the incubation of a reactive derivative of PEG with the target molecule. The covalent...

Read more Adagen Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/PEGylation

Recent Adagen Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Pegademase Bovine
  • Injection: 250 units/ml, 250unit/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Adagen: (1 result)

Sorted by National Drug Code
  • 57665-001 Adagen 250 [iu]/Ml Intramuscular Injection, Solution by Sigma-tau Pharmaceuticals, Inc.

Other drugs which contain Pegademase Bovine or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA